74 research outputs found

    An evolvable space telescope for future astronomical missions

    Get PDF
    Astronomical flagship missions after JWST will require affordable space telescopes and science instruments. Innovative spacecraft-electro-opto-mechanical system architectures matched to the science requirements are needed for observations for exoplanet characterization, cosmology, dark energy, galactic evolution formation of stars and planets, and many other research areas. The needs and requirements to perform this science will continue to drive us toward larger and larger apertures. Recent technology developments in precision station keeping of spacecraft, interplanetary transfer orbits, wavefront/sensing and control, laser engineering, macroscopic application of nano-technology, lossless optical designs, deployed structures, thermal management, interferometry, detectors and signal processing enable innovative telescope/system architectures with break-through performance. Unfortunately, NASA’s budget for Astrophysics is unlikely to be able to support the funding required for the 8 m to 16 m telescopes that have been studied as a follow-on to JWST using similar development/assembly approaches without decimating the rest of the Astrophysics Division’s budget. Consequently, we have been examining the feasibility of developing an “Evolvable Space Telescope” that would begin as a 3 to 4 m telescope when placed on orbit and then periodically be augmented with additional mirror segments, structures, and newer instruments to evolve the telescope and achieve the performance of a 16 m or larger space telescope. This paper reviews the approach for such a mission and identifies and discusses candidate architectures

    An evolvable space telescope for future astronomical missions 2015 update

    Get PDF
    In 2014 we presented a concept for an Evolvable Space Telescope (EST) that was assembled on orbit in 3 stages, growing from a 4x12 meter telescope in Stage 1, to a 12-meter filled aperture in Stage 2, and then to a 20-meter filled aperture in Stage 3. Stage 1 is launched as a fully functional telescope and begins gathering science data immediately after checkout on orbit. This observatory is then periodically augmented in space with additional mirror segments, structures, and newer instruments to evolve the telescope over the years to a 20-meter space telescope. In this 2015 update of EST we focus upon three items: 1) a restructured Stage 1 EST with three mirror segments forming an off-axis telescope (half a 12-meter filled aperture); 2) more details on the value and architecture of the prime focus instrument accommodation; and 3) a more in depth discussion of the essential in-space infrastructure, early ground testing and a concept for an International Space Station testbed called MoDEST. In addition to the EST discussions we introduce a different alternative telescope architecture: a Rotating Synthetic Aperture (RSA). This is a rectangular primary mirror that can be rotated to fill the UV-plane. The original concept was developed by Raytheon Space and Airborne Systems for non-astronomical applications. In collaboration with Raytheon we have begun to explore the RSA approach as an astronomical space telescope and have initiated studies of science and cost performance

    Innovative telescope architectures for future large space observatories

    Get PDF
    Over the past few years, we have developed a concept for an evolvable space telescope (EST) that is assembled on orbit in three stages, growing from a 4×12-m telescope in Stage 1, to a 12-m filled aperture in Stage 2, and then to a 20-m filled aperture in Stage 3. Stage 1 is launched as a fully functional telescope and begins gathering science data immediately after checkout on orbit. This observatory is then periodically augmented in space with additional mirror segments, structures, and newer instruments to evolve the telescope over the years to a 20-m space telescope. We discuss the EST architecture, the motivation for this approach, and the benefits it provides over current approaches to building and maintaining large space observatories

    Control of intestinal stem cell function and proliferation by mitochondrial pyruvate metabolism.

    Get PDF
    Most differentiated cells convert glucose to pyruvate in the cytosol through glycolysis, followed by pyruvate oxidation in the mitochondria. These processes are linked by the mitochondrial pyruvate carrier (MPC), which is required for efficient mitochondrial pyruvate uptake. In contrast, proliferative cells, including many cancer and stem cells, perform glycolysis robustly but limit fractional mitochondrial pyruvate oxidation. We sought to understand the role this transition from glycolysis to pyruvate oxidation plays in stem cell maintenance and differentiation. Loss of the MPC in Lgr5-EGFP-positive stem cells, or treatment of intestinal organoids with an MPC inhibitor, increases proliferation and expands the stem cell compartment. Similarly, genetic deletion of the MPC in Drosophila intestinal stem cells also increases proliferation, whereas MPC overexpression suppresses stem cell proliferation. These data demonstrate that limiting mitochondrial pyruvate metabolism is necessary and sufficient to maintain the proliferation of intestinal stem cells

    Transmission of mitochondrial DNA following assisted reproduction and nuclear transfer

    Get PDF
    Review of the articleMitochondria are the organelles responsible for producing the majority of a cell's ATP and also play an essential role in gamete maturation and embryo development. ATP production within the mitochondria is dependent on proteins encoded by both the nuclear and the mitochondrial genomes, therefore co-ordination between the two genomes is vital for cell survival. To assist with this co-ordination, cells normally contain only one type of mitochondrial DNA (mtDNA) termed homoplasmy. Occasionally, however, two or more types of mtDNA are present termed heteroplasmy. This can result from a combination of mutant and wild-type mtDNA molecules or from a combination of wild-type mtDNA variants. As heteroplasmy can result in mitochondrial disease, various mechanisms exist in the natural fertilization process to ensure the maternal-only transmission of mtDNA and the maintenance of homoplasmy in future generations. However, there is now an increasing use of invasive oocyte reconstruction protocols, which tend to bypass mechanisms for the maintenance of homoplasmy, potentially resulting in the transmission of either form of mtDNA heteroplasmy. Indeed, heteroplasmy caused by combinations of wild-type variants has been reported following cytoplasmic transfer (CT) in the human and following nuclear transfer (NT) in various animal species. Other techniques, such as germinal vesicle transfer and pronuclei transfer, have been proposed as methods of preventing transmission of mitochondrial diseases to future generations. However, resulting embryos and offspring may contain mtDNA heteroplasmy, which itself could result in mitochondrial disease. It is therefore essential that uniparental transmission of mtDNA is ensured before these techniques are used therapeutically

    Advanced Technology Large-Aperture Space Telescope (ATLAST): A Technology Roadmap for the Next Decade

    Full text link
    The Advanced Technology Large-Aperture Space Telescope (ATLAST) is a set of mission concepts for the next generation of UVOIR space observatory with a primary aperture diameter in the 8-m to 16-m range that will allow us to perform some of the most challenging observations to answer some of our most compelling questions, including "Is there life elsewhere in the Galaxy?" We have identified two different telescope architectures, but with similar optical designs, that span the range in viable technologies. The architectures are a telescope with a monolithic primary mirror and two variations of a telescope with a large segmented primary mirror. This approach provides us with several pathways to realizing the mission, which will be narrowed to one as our technology development progresses. The concepts invoke heritage from HST and JWST design, but also take significant departures from these designs to minimize complexity, mass, or both. Our report provides details on the mission concepts, shows the extraordinary scientific progress they would enable, and describes the most important technology development items. These are the mirrors, the detectors, and the high-contrast imaging technologies, whether internal to the observatory, or using an external occulter. Experience with JWST has shown that determined competitors, motivated by the development contracts and flight opportunities of the new observatory, are capable of achieving huge advances in technical and operational performance while keeping construction costs on the same scale as prior great observatories.Comment: 22 pages, RFI submitted to Astro2010 Decadal Committe

    The James Webb Space Telescope Mission

    Full text link
    Twenty-six years ago a small committee report, building on earlier studies, expounded a compelling and poetic vision for the future of astronomy, calling for an infrared-optimized space telescope with an aperture of at least 4m4m. With the support of their governments in the US, Europe, and Canada, 20,000 people realized that vision as the 6.5m6.5m James Webb Space Telescope. A generation of astronomers will celebrate their accomplishments for the life of the mission, potentially as long as 20 years, and beyond. This report and the scientific discoveries that follow are extended thank-you notes to the 20,000 team members. The telescope is working perfectly, with much better image quality than expected. In this and accompanying papers, we give a brief history, describe the observatory, outline its objectives and current observing program, and discuss the inventions and people who made it possible. We cite detailed reports on the design and the measured performance on orbit.Comment: Accepted by PASP for the special issue on The James Webb Space Telescope Overview, 29 pages, 4 figure

    Transmission of Yellow Fever Vaccine Virus Through Blood Transfusion and Organ Transplantation in the USA in 2021: Report of an Investigation

    Get PDF
    BACKGROUND: In 2021, four patients who had received solid organ transplants in the USA developed encephalitis beginning 2-6 weeks after transplantation from a common organ donor. We describe an investigation into the cause of encephalitis in these patients. METHODS: From Nov 7, 2021, to Feb 24, 2022, we conducted a public health investigation involving 15 agencies and medical centres in the USA. We tested various specimens (blood, cerebrospinal fluid, intraocular fluid, serum, and tissues) from the organ donor and recipients by serology, RT-PCR, immunohistochemistry, metagenomic next-generation sequencing, and host gene expression, and conducted a traceback of blood transfusions received by the organ donor. FINDINGS: We identified one read from yellow fever virus in cerebrospinal fluid from the recipient of a kidney using metagenomic next-generation sequencing. Recent infection with yellow fever virus was confirmed in all four organ recipients by identification of yellow fever virus RNA consistent with the 17D vaccine strain in brain tissue from one recipient and seroconversion after transplantation in three recipients. Two patients recovered and two patients had no neurological recovery and died. 3 days before organ procurement, the organ donor received a blood transfusion from a donor who had received a yellow fever vaccine 6 days before blood donation. INTERPRETATION: This investigation substantiates the use of metagenomic next-generation sequencing for the broad-based detection of rare or unexpected pathogens. Health-care workers providing vaccinations should inform patients of the need to defer blood donation for at least 2 weeks after receiving a yellow fever vaccine. Despite mitigation strategies and safety interventions, a low risk of transfusion-transmitted infections remains. FUNDING: US Centers for Disease Control and Prevention (CDC), the Biomedical Advanced Research and Development Authority, and the CDC Epidemiology and Laboratory Capacity Cooperative Agreement for Infectious Diseases
    • 

    corecore